Company Filing History:
Years Active: 2014-2020
Title: Innovations by Inventor Theo De Vos
Introduction
Theo De Vos is an accomplished inventor based in Seattle, WA (US). She has made significant contributions to the field of biotechnology, particularly in the analysis of DNA and its methylation patterns. With a total of 2 patents, her work has implications for both diagnostics and therapeutic approaches in medicine.
Latest Patents
One of her latest patents is titled "Method for determining the presence or absence of methylation in a sample." This invention relates to compositions and methods for providing DNA fragments from a remote sample. It involves isolating DNA from a remote sample and treating it to differentiate between methylated and unmethylated cytosine. The patent also covers methods for analyzing DNA derived from various human samples, including blood, plasma, serum, and urine.
Another significant patent is "Method and nucleic acids for the analysis of colorectal cell proliferative disorders." This invention provides methods and nucleic acids for detecting and differentiating colon cell proliferative disorders. It focuses on the gene EYA4 and its regulatory sequences, offering novel nucleic acid sequences useful for specific analysis of this gene, along with associated methods, assays, and kits.
Career Highlights
Theo De Vos is currently associated with Epigenomics AG, where she continues to advance her research in the field of epigenetics. Her work has been instrumental in developing innovative methods for DNA analysis, which are crucial for understanding various health conditions.
Collaborations
Throughout her career, she has collaborated with notable colleagues, including Matthias Ballhause and Kurt Berlin. These collaborations have further enriched her research and contributed to the success of her inventions.
Conclusion
Theo De Vos is a pioneering inventor whose work in DNA analysis and methylation has the potential to transform medical diagnostics and treatment. Her contributions to the field are significant and continue to influence ongoing research and development.